Literature DB >> 12884285

A minimal human immunostimulatory CpG motif that potently induces IFN-gamma and IFN-alpha production.

Karen Fearon1, Jason D Marshall, Christi Abbate, Sandhya Subramanian, Priscilla Yee, Josh Gregorio, Glen Teshima, Gary Ott, Stephen Tuck, Gary Van Nest, Robert L Coffman.   

Abstract

Recent reports have shown that immunostimulatory sequences (ISS) containing CpG motifs have minimal length requirements (>/=12 bases) for the exertion of immune-enhancing function upon mammalian cells. Herein we demonstrate that short ISS (5-7 bases), which exhibit no activity on their own, induce IFN-gamma and IFN-alpha secretion from human peripheral blood mononuclear cells when adsorbed to the surface of cationic poly(D,L-lactide-co-glycolide) microparticles (cPLGA). Utilizing this technique, we discovered a minimal ISS sequence for induction of IFN-gamma and IFN-alpha from human cells: 5'-TCGXX-3'. These short ISS/cPLGA formulations targeted PDC in similar fashion to longer ISS ODN, the activity of which does not require (but is enhanced by) cPLGA. PDC stimulated with short ISS/cPLGA responded with enhanced uptake of ISS and elevated production of cytokines, including IFN-alpha. However, ISS-responsive B cells did not respond to short ISS/cPLGA, underlining the plasmacytoid dendritic cell selectivity of this formulation. These results describe a novel technique for formulating active, but very short, ISS oligodeoxynucleotide that allows for the dissection and characterization of minimal immunostimulatory CpG motifs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884285     DOI: 10.1002/eji.200323948

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides.

Authors:  Klaus Zwiorek; Carole Bourquin; Julia Battiany; Gerhard Winter; Stefan Endres; Gunther Hartmann; Conrad Coester
Journal:  Pharm Res       Date:  2007-10-03       Impact factor: 4.200

2.  The discovery of potent immunostimulatory CpG-ODNs widely distributed in bacterial genomes.

Authors:  Juan Liu; Yan Wei; Yongling Lu; Yangyuling Li; Qian Chen; Yan Li
Journal:  J Microbiol       Date:  2019-12-23       Impact factor: 3.422

3.  Novel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cells.

Authors:  Jason D Marshall; Edith M Hessel; Josh Gregorio; Christina Abbate; Priscilla Yee; Mabel Chu; Gary Van Nest; Robert L Coffman; Karen L Fearon
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

4.  CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans.

Authors:  John D Campbell; Yan Cho; Martyn L Foster; Holger Kanzler; Melissa A Kachura; Jeremy A Lum; Marianne J Ratcliffe; Atul Sathe; Andrew J Leishman; Ash Bahl; Mark McHale; Robert L Coffman; Edith M Hessel
Journal:  J Clin Invest       Date:  2009-08-10       Impact factor: 14.808

Review 5.  Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.

Authors:  Nobutaka Hanagata
Journal:  Int J Nanomedicine       Date:  2012-04-27

6.  Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.

Authors:  Edith M Hessel; Mabel Chu; Jennifer O Lizcano; Bonnie Chang; Nancy Herman; Sariah A Kell; Marsha Wills-Karp; Robert L Coffman
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

7.  Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells.

Authors:  Ada Funaro; Giorgio Gribaudo; Anna Luganini; Erika Ortolan; Nicola Lo Buono; Elisa Vicenzi; Luca Cassetta; Santo Landolfo; Richard Buick; Luca Falciola; Marianne Murphy; Gianni Garotta; Fabio Malavasi
Journal:  BMC Biotechnol       Date:  2008-11-12       Impact factor: 2.563

8.  Broad-spectrum drugs against viral agents.

Authors:  Mary E Christopher; Jonathan P Wong
Journal:  Int J Mol Sci       Date:  2008-09-01       Impact factor: 6.208

9.  A Novel C Type CpG Oligodeoxynucleotide Exhibits Immunostimulatory Activity In Vitro and Enhances Antitumor Effect In Vivo.

Authors:  Tete Li; Jing Wu; Shan Zhu; Guoxia Zang; Shuang Li; Xinping Lv; Wenjun Yue; Yuan Qiao; Jiuwei Cui; Yan Shao; Jun Zhang; Yong-Jun Liu; Jingtao Chen
Journal:  Front Pharmacol       Date:  2020-02-06       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.